Primary infection with HIV leads to severe depletion of CD4 T cells. This effect is conveniently measured in the blood compartment, but is even more pronounced in the gastrointestinal tract, which may be the initial site of acquisition of HIV for some people. Persistent HIV gastrointestinal infection impairs local immune defences, leads to immune activation and disrupts the epithelial barrier. The epithelial dysfunction is not completely repaired by anti‐retroviral therapy (ART) that is effective enough to suppress HIV viral load in the blood to undetectable levels. At the microscopic level, disruption of tight junctions between adjacent columnar epithelial cells is seen as a component. The resulting loss of integrity of the epithelium allows translocation of bacteria into the bloodstream, and this has been investigated as a potential contributor to the chronic systemic inflammation seen in HIV patients. These studies have now been supplemented by investigations to detect a viral pathogen in the gastrointestinal tract. Cytomegalovirus is found in the vast majority of HIV‐positive patients. Opportunistic diseases, usually retinitis, caused by high viral loads of CMV are nowadays mostly prevented by ART, where this is available. However, there is extensive evidence that CMV infection, as opposed to overt disease, is not completely controlled by ART. It is known to infect endothelial, stromal and intestinal epithelial cells and may form ulcers to compromise the barrier function of the mucosa. It is known to disrupt tight junctions of retinal pigment epithelial cells, so might be able to do the same in epithelial cells of the gastrointestinal tract. It is possible therefore that it may contribute to the chronic gastrointestinal and systemic inflammation seen in HIV‐positive patients. A recent publication combined immunohistochemistry with in situ hybridisation on primary intestinal cells differentiated to form monolayers of polarised cells. In this system, CMV decreased trans‐epithelial electrical resistance, a method used to assess the integrity of an epithelial monolayer. Permeability was also changed when assessed by the ability of dextran labelled with a fluorescent dye to migrate across cells held in the compartments of a trans‐well apparatus. Only a few cells were CMV positive, raising the question of how an infection of limited scale could produce an effect across the whole epithelium. A contribution from interleukin‐6 was identified, with the effect on epithelial integrity partially reduced by an antibody that blocked interleukin‐6. The antiviral drugs ganciclovir or letermovir reduced the effect of CMV on the epithelium. Parallel studies on biopsies of rectosigmoid tissue provided evidence that similar effects take place in vivo. The CMV proteins were readily detected in untreated
[1]
E. Maidji,et al.
Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction
,
2017,
PLoS pathogens.
[2]
M. Reeves,et al.
Cytomegalovirus latency and reactivation: recent insights into an age old problem
,
2016,
Reviews in medical virology.
[3]
E. Sinclair,et al.
Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.
,
2011,
The Journal of infectious diseases.
[4]
M. Lederman,et al.
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.
,
2009,
The Journal of infectious diseases.
[5]
D. Price,et al.
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
,
2004,
The Journal of experimental medicine.
[6]
C. Sabin,et al.
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy
,
2004,
The Lancet.
[7]
J. Kempen,et al.
Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome.
,
2003,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8]
P. Griffiths,et al.
Studies of viral co-factors for human immunodeficiency virus in vitro and in vivo.
,
1998,
The Journal of general virology.
[9]
S. Spector,et al.
Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients.
,
1998,
The Journal of clinical investigation.
[10]
S. Aho,et al.
CYTOMEGALOVIRUS INFECTION AND PROGRESSION TO AIDS
,
1989,
The Lancet.
[11]
R. H. Rubin.
The indirect effects of cytomegalovirus infection on the outcome of organ transplantation.
,
1989,
JAMA.
[12]
S. Tugizov,et al.
Role of apical and basolateral membranes in replication of human cytomegalovirus in polarized retinal pigment epithelial cells.
,
1996,
The Journal of general virology.